drugset / Trial / NCT03555032
TITAN (Tumoural Injection of T-VEC and Isolated Limb Perfusion)
NaSingle-groupOpen-labelTreatment
Summary
This study will look at the safety and effects of combining a new drug called Talimogene Laherparepvec (T-VEC) with chemotherapy delivered by Isolated Limb Perfusion (ILP). The investigators want to find out whether these two treatments can be combined safely and whether T-VEC with ILP is better at treating your cancer than with ILP alone.
Timeline
- Start
- 2018-06-26
- Primary completion
- 2021-08-01
- Completion
- 2021-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Talimogene Laherparepvec | Other / unclassified | 1e+06 unknown | Other |
| Subject | Talimogene Laherparepvec | Other / unclassified | 1e+08 unknown | Other |